The Nurse Is Health Care’s Most Underpriced Founder
They see the problem first, build the fix, and decide whether it is ever adopted. The market has trained them to hide the one credential that de-risks the deal.
What Health Tech Investors Love in Founders — and What They Can’t Stand
Health tech investors say the founders who win them over aren't the ones with all the answers, but the ones who know exactly what they don't know — and build a team to cover the gap.
presented by
From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
Healthcare’s Next Source of Alpha Is Moving Upstream
The question is no longer whether healthcare innovation is accelerating. The question is where investors gain access to generate the strongest returns.
What Happens to Independent Medicine When Private Equity Shows Up With a Checkbook
This is not an argument against capital in independent medicine. Practices need infrastructure, and physicians have legitimate reasons to seek liquidity. It is an argument that the exit stage carries a risk this market has not yet priced.
Revenue Isn’t the Signal: What Early-Stage Health Tech Investors Should Be Watching Instead
What matters just as much — if not more — is everything around that number: how customers adopt the product, how sales actually happen, and whether the company is building something that can scale inside a complex, regulated system.
The Opportunity being Missed in UK Healthcare Buyouts
Following Brexit, the funding infrastructure for new buyout funds in the UK has broken down. These new managers are now struggling to find anchor investors and offer an opportunity to the private sector to step in and secure attractive returns.
presented by
Closing the Quality-Affordability Gap in Workplace Mental Health
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
The ICHRA Moment Is Here — Are You Ready for It?
ICHRA is surging in popularity as an option for employer-sponsored insurance to access the individual market, as employers rethink traditional group plans with unpredictable renewal rates and employees seek personalized healthcare. Here's a closer look at why investors and politicians are eyeing ICHRA.
Google’s Olympics Misstep and the Real AI Opportunity
While Google showcases AI's ability to mimic human sentimentality, it misses the forest for the trees. The real innovation, the true potential of AI, lies not in replacing human expression but in enhancing human lives, particularly those of our rapidly aging population.
This New Venture Firm Thinks Payers Will Be the Ones to Drive Change in the Healthcare Industry
Create Health Ventures announced the close of its inaugural $21 million fund, which is focused on technology for payers. This is because payers are “the lynchpin” for the types of change that the fund wants to see, such as better care access and improved population health outcomes, Managing Partner Amit Aysola said.
5 Things to Know About How NIH’s SEED Can Help Life Science Startups Grow
The NIH’s SEED office formed to help startups leverage government’s funding programs. Chris Sasiela, director of the SEED office, discussed these programs during the MedCity News INVEST Conference in Chicago.
presented by
Automation Didn’t Dehumanize Care. Bad Systems Did.
We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.
4 Things Digital Health Investors Need To Get Off Their Chest
During a panel at MedCity News’ INVEST conference, venture capitalists shared some of their takes on today’s healthcare funding landscape — including their thoughts on AI and the industry’s slower investment pace.
Portfolio Management Strategies for Growth and Impact in Cell and Gene
As cell and gene therapies continue to make headlines as a key opportunity for growth, success in this field will require both innovative tech as well as strategic foresight.
Want to Connect with Innovative Healthcare Startups and Investors? Register for MedCity INVEST Today!
In addition to panel discussions around some of the hottest topics in healthcare transformation, there is also a startup pitch contest, a presentation on government funding for startups and networking opportunities.
Don’t Miss the Best Boutique Healthcare Investment Conference — Register for MedCity INVEST Today!
MedCity INVEST 2024, scheduled for May 21-22 at the Ritz Carlton hotel in Chicago, is the ideal event to discuss healthcare funding with investors looking for investment opportunities.
Network With Healthcare Investors at MedCity INVEST 2024!
The conference, scheduled for May 21-22 at the Ritz Carlton hotel in Chicago, brings together healthcare investors, startups, and innovative-minded executives. Register today!